Cargando…

CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta‐analysis

BACKGROUND: CGRP monoclonal antibody (mAb) is a promising preventive treatment for episodic migraine and has been approved by US FDA recently. But the treatments for chronic migraine are rare. Therefore, we performed meta‐analysis to assess the efficacy and safety of CGRP mAbs in preventing chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Lin, Liu, Yao, Xiong, Hai, Hong, Peiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379644/
https://www.ncbi.nlm.nih.gov/pubmed/30656853
http://dx.doi.org/10.1002/brb3.1215